RYTHM (RYM) and Its Competitors Head to Head Survey

RYTHM (NASDAQ:RYM) is one of 902 publicly-traded companies in the “Pharmaceuticals” industry, but how does it weigh in compared to its peers? We will compare RYTHM to similar companies based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership.

Risk and Volatility

RYTHM has a beta of 9.44, indicating that its stock price is 844% more volatile than the S&P 500. Comparatively, RYTHM’s peers have a beta of -3.12, indicating that their average stock price is 412% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations and price targets for RYTHM and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RYTHM	1	0	0	0	1.00
RYTHM Competitors	7598	13660	25483	1002	2.42

As a group, “Pharmaceuticals” companies have a potential upside of 25.89%. Given RYTHM’s peers stronger consensus rating and higher possible upside, analysts plainly believe RYTHM has less favorable growth aspects than its peers.

Profitability

This table compares RYTHM and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
RYTHM	-6.20%	-12.57%	-2.60%
RYTHM Competitors	-2,319.38%	-223.57%	-16.98%

Valuation & Earnings

This table compares RYTHM and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
RYTHM	$17.28 million	-$33.26 million	-2.23
RYTHM Competitors	$3.57 billion	$3.15 billion	547.43

RYTHM’s peers have higher revenue and earnings than RYTHM. RYTHM is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

6.0% of RYTHM shares are held by institutional investors. Comparatively, 32.8% of shares of all “Pharmaceuticals” companies are held by institutional investors. 3.5% of RYTHM shares are held by company insiders. Comparatively, 14.2% of shares of all “Pharmaceuticals” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

RYTHM peers beat RYTHM on 9 of the 13 factors compared.

RYTHM Company Profile

Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.